An Agentic AI Approach to Predicting Immunotherapy Response
Immune checkpoint inhibitors have transformed cancer care, yet only about 1 in 5 patients respond to PD-1 blockade. Predicting who will respond remains one of oncology's biggest unsolved challenges. In this webinar, scientists from Mithrl and Elephas will share how combining functional tumor profiling with agentic AI can reduce that uncertainty, integrating real-time cytokine data...
